PRESS RELEASE

SVAS BIOSANA S.p.A.

TAKES PART IN THE THIRD EDITION OF "MID & SMALL VIRTUAL 2022"

TO MEET WITH INSTITUTIONAL INVESTORS

Somma Vesuviana (Naples) 28 June 2022 - Svas Biosana S.p.A., ("the Company" or "SVAS", a leading player in the production and distribution of medical devices for public and private healthcare facilities, and listed on Euronext Growth Milan, a multilateral trading system organised and managed by Borsa Italiana S.p.A. which focuses on small and medium-sized companies with high growth potential - reports that on 2022 June, it will be taking part in the third edition of the Mid & Small Conference, Virtual Edition 2022.

The Conference, which is organised by Virgilio IR in a partnership with CDR Communication - and sponsored by BANCA AKROS, BANCA PROFILO, BPER BANCA and CFO SIM - will take place on-line on Tuesday 28, Wednesday 29 and Thursday, 30 June 2022.

"Participation in the Mid & Small Conference Virtual Edition 2022 provides an opportunity to meet with institutional investors" - Umberto Perillo, CEO of Svas, declares - "We are proud to share and update the

market with the results recorded for Q1 2022 and our Group's recent acquisition, as well as to present our

growth prospects".

The institutional presentation will be made available on the day of the event in the Investor Relations / Presentations section of the Company's website.

* * * * * *

This press release can be found at Borsa Italiana, at the Company's registered office, and in the Investor Relations/Financial Press Releases section of the website www.svas.it. Svas Biosana uses the eMarket SDIR system, managed by Spafid Connect S.p.A., with registered office at Foro Buonaparte 10, Milan (www.emarketstorage.com), to disclose regulated information.

Contacts:

SVAS Biosana S.p.A.

Euronext Growth Advisor

Andrea Efficace

Banca Profilo

CFO Group and Investor Relations Manager

Via Cerva 128, Milan

+39 081.8995411

+39 02.584081

a.efficace@svas.it

alessio.muretti@bancaprofilo.it

SVAS BIOSANA S.p.A.

Registered Office

Correspondence

Headquarters and

Contacts

Offices

Companies Register of

Via M. Perillo, 34

Post Box 91

Via Trentola, 7

Tel. +390818995411

Naples no. 4543/85

80047

80049

80049

Fax +390818993922

Economic and

San Giuseppe Vesuviano (NA)

Somma Vesuviana (NA)

Somma Vesuviana (NA)

www.svas.it

Administrative Index no.

Tax Code 04720630633

Italy

Italy

Italy

svasbiosana@legalmail.it

VAT no. 01354901215

Investor Relations Advisor

Media Relations Advisor

POLYTEMS HIR

POLYTEMS HIR

Bianca FERSINI MASTELLONI - Silvia MARONGIU

Paolo SANTAGOSTINO

06.69923324-066797849

+393493856585

s.marongiu@polytemshir.it

p.santagostino@polytemshir.it

Specialist

Banca Profilo

+39 02.584081

Svas Biosana manufactures and distributes medical devices in Italy and abroad. Founded in 1972 in Somma Vesuviana (NA) by the Perillo family, SVAS is now an international company with a catalogue of approximately 16,000 own and third party brand products, roughly 370 employees, a Research and Development department, 3 production facilities in Italy and subsidiaries in Slovenia, Croatia, Serbia and Bosnia- Herzegovina.

Ticker: ISIN Ordinary Shares: IT0005469264 Ticker: ISIN Warrant SVAS BIOSANA 2021-2024: IT0005469157

SVAS BIOSANA S.p.A.

Registered Office

Correspondence

Headquarters and

Contacts

Offices

Companies Register of

Via M. Perillo, 34

Post Box 91

Via Trentola, 7

Tel. +390818995411

Naples no. 4543/85

80047

80049

80049

Fax +390818993922

Economic and

San Giuseppe Vesuviano (NA)

Somma Vesuviana (NA)

Somma Vesuviana (NA)

www.svas.it

Administrative Index no.

Tax Code 04720630633

Italy

Italy

Italy

svasbiosana@legalmail.it

VAT no. 01354901215

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Svas Biosana S.p.A. published this content on 28 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2022 12:20:06 UTC.